ES2095874T3 - Vacuna acelular. - Google Patents

Vacuna acelular.

Info

Publication number
ES2095874T3
ES2095874T3 ES90907222T ES90907222T ES2095874T3 ES 2095874 T3 ES2095874 T3 ES 2095874T3 ES 90907222 T ES90907222 T ES 90907222T ES 90907222 T ES90907222 T ES 90907222T ES 2095874 T3 ES2095874 T3 ES 2095874T3
Authority
ES
Spain
Prior art keywords
vaccine
cellular vaccine
antigens
pertussis
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90907222T
Other languages
English (en)
Other versions
ES2095874T5 (es
Inventor
Pavel Novotny
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medeva Holdings BV
Original Assignee
Medeva Holdings BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10656410&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2095874(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medeva Holdings BV filed Critical Medeva Holdings BV
Publication of ES2095874T3 publication Critical patent/ES2095874T3/es
Application granted granted Critical
Publication of ES2095874T5 publication Critical patent/ES2095874T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Liquid Crystal Substances (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTA UNA VACUNA ACELULAR QUE CUANDO SE UTILIZA PROPORCIONA UNA PROTECCION CONTRA INFECCIONES DE LA BORDETELLA PERTUSSIS. LA VACUNA SE BASA EN LA COMBINACION SINERGISTICA DE DOS ANTIGENOS DE LA B. PERTUSSIS, EL KDA 69 Y LOS ANTIGENOS DE HEMAGLUTININA FILAMENTOSOS.
ES90907222T 1989-05-08 1990-04-26 Vacuna acelular. Expired - Lifetime ES2095874T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898910570A GB8910570D0 (en) 1989-05-08 1989-05-08 Acellular vaccine
GB8910570 1989-05-08

Publications (2)

Publication Number Publication Date
ES2095874T3 true ES2095874T3 (es) 1997-03-01
ES2095874T5 ES2095874T5 (es) 2008-11-01

Family

ID=10656410

Family Applications (3)

Application Number Title Priority Date Filing Date
ES90907222T Expired - Lifetime ES2095874T5 (es) 1989-05-08 1990-04-26 Vacuna acelular.
ES96112324T Expired - Lifetime ES2230555T3 (es) 1989-05-08 1990-04-26 Vacuna acelular.
ES04018329T Expired - Lifetime ES2322352T3 (es) 1989-05-08 1990-04-26 Procedimiento de produccion de una vacuna acelular que contiene antigenos de bordetella pertussis.

Family Applications After (2)

Application Number Title Priority Date Filing Date
ES96112324T Expired - Lifetime ES2230555T3 (es) 1989-05-08 1990-04-26 Vacuna acelular.
ES04018329T Expired - Lifetime ES2322352T3 (es) 1989-05-08 1990-04-26 Procedimiento de produccion de una vacuna acelular que contiene antigenos de bordetella pertussis.

Country Status (12)

Country Link
US (1) US7479283B1 (es)
EP (3) EP1666057B1 (es)
JP (2) JP3281369B2 (es)
AT (3) ATE422900T1 (es)
DE (14) DE69034264D1 (es)
DK (3) DK1666057T3 (es)
ES (3) ES2095874T5 (es)
FR (1) FR09C0033I1 (es)
GB (1) GB8910570D0 (es)
LU (15) LU90204I2 (es)
NL (13) NL980007I1 (es)
WO (1) WO1990013313A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
GB9021004D0 (en) * 1990-09-27 1990-11-07 Wellcome Found Acellular vaccines
GB9209118D0 (en) * 1992-04-28 1992-06-10 Sb 120 Amsterdam Bv Vaccine compositions
FR2754543B1 (fr) * 1996-10-11 1998-12-31 Pasteur Institut Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires
US7022522B2 (en) 1998-11-13 2006-04-04 Limin Guan Macroporous polymer scaffold containing calcium phosphate particles
US8574596B2 (en) * 2003-10-02 2013-11-05 Glaxosmithkline Biologicals, S.A. Pertussis antigens and use thereof in vaccination
US8877201B2 (en) * 2007-10-25 2014-11-04 Wake Forest University Health Sciences Bordetella outer-membrane protein antigens and methods of making and using the same
EP2250144A4 (en) 2008-03-07 2014-06-04 Arkema Inc FORMULATED AND STABLE SYSTEMS CONTAINING CHLORO-3,3,3-TRIFLUOROPROPENE
GB201105981D0 (en) 2011-04-08 2011-05-18 Glaxosmithkline Biolog Sa Novel process
BR112015021523A8 (pt) 2013-03-08 2021-06-29 Crucell Holland Bv composição de uma vacina contra a tosse convulsa acelular, e, usos da composição e de antígenos da bordetella pertussis
CA2923129C (en) 2013-09-08 2020-06-09 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
WO2016132294A1 (en) 2015-02-19 2016-08-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047886A1 (en) 1969-06-30 1971-03-19 Merieux Inst Non-toxic anti-whooping cough vaccine
DE3176347D1 (en) 1980-06-27 1987-09-17 Ciba Geigy Ag Synergistic agents and method for the selective control of weeds, particularly in cereals and soybeans
JPS5750925A (en) 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
JPS58222032A (ja) 1982-06-18 1983-12-23 Teijin Ltd 百日咳毒素のサブユニツト蛋白
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
US5237052A (en) * 1984-05-12 1993-08-17 Burroughs Wellcome Company Antigenic preparations and isolation of such preparations
JPS6176422A (ja) * 1984-09-22 1986-04-18 Chemo Sero Therapeut Res Inst 百日ぜきコンポ−ネントワクチンおよび百日ぜき・ジフテリア・破傷風混合ワクチンの製造方法
FR2590483B1 (fr) 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
EP0267498B1 (de) * 1986-11-11 1993-01-27 Siemens Aktiengesellschaft Flusskompensierter Stromwandler
FR2606789B1 (fr) 1986-11-17 1991-05-31 Pasteur Institut Preparations d'adenylate cyclase purifiees, procede d'obtention de ces preparations et leurs applications biologiques
EP0267998A1 (en) * 1986-11-17 1988-05-25 Institut Pasteur Means for protecting against bordetella infections and toxic processes
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
GB8807860D0 (en) 1988-04-05 1988-05-05 Connaught Lab Pertussis vaccine
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis
US5162223A (en) * 1989-02-17 1992-11-10 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Resources Hybridomas and resulting monoclonal antibodies directed against antigens of Bordetella pertussis
GB8910570D0 (en) 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US5276142A (en) 1989-12-11 1994-01-04 American Cyanamid Company Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis
GB9007416D0 (en) 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9007657D0 (en) 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
IT1248735B (it) 1990-06-21 1995-01-26 Sclavo Spa Vaccini acellulari contro la pertosse
EP0484621A3 (en) 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
AU2352595A (en) 1994-04-28 1995-11-29 Takeda Chemical Industries Ltd. Method of separating protective components of bordetella pertussis
US5972225A (en) * 1996-05-07 1999-10-26 Cook Imaging Corporation Process for remediating endotoxin-contaminated bulk non-ionic contrast media

Also Published As

Publication number Publication date
LU90204I2 (fr) 1998-04-06
DE122005000020I1 (de) 2005-06-23
EP1666057B1 (en) 2009-02-18
FR09C0033I1 (es) 2009-09-25
NL300404I1 (en) 2009-10-01
ES2322352T3 (es) 2009-06-19
DE69034166T2 (de) 2005-08-04
DE69029656T2 (de) 1997-04-24
JP2002226397A (ja) 2002-08-14
NL300189I1 (nl) 2005-06-01
LU91596I2 (fr) 2009-10-12
DK0471726T4 (da) 2008-09-15
EP1666057A3 (en) 2008-06-04
LU91153I2 (fr) 2005-06-23
LU91149I2 (fr) 2005-06-23
DE122009000043I1 (de) 2009-11-05
NL300187I1 (nl) 2005-06-01
LU91150I2 (fr) 2005-06-23
EP0471726A1 (en) 1992-02-26
EP0747058B1 (en) 2004-09-22
DE69029656T3 (de) 2009-06-04
ATE276759T1 (de) 2004-10-15
LU91593I2 (fr) 2009-10-12
DK1666057T3 (da) 2009-06-08
NL300183I1 (nl) 2005-06-01
ATE147271T1 (de) 1997-01-15
DE122005000018I1 (de) 2005-06-23
NL300403I1 (en) 2009-10-01
NL300188I1 (nl) 2005-06-01
NL300186I1 (nl) 2005-06-01
GB8910570D0 (en) 1989-06-21
EP1666057A2 (en) 2006-06-07
WO1990013313A1 (en) 1990-11-15
NL300184I1 (nl) 2005-06-01
NL300402I1 (en) 2009-10-01
LU91151I2 (fr) 2005-06-23
DE69034264D1 (de) 2009-04-02
LU91154I2 (fr) 2005-06-23
JPH04505158A (ja) 1992-09-10
DE122005000019I1 (de) 2005-06-23
LU91597I2 (fr) 2009-10-12
DE122005000015I1 (de) 2005-11-24
JP3281369B2 (ja) 2002-05-13
LU91594I2 (fr) 2009-10-12
US7479283B1 (en) 2009-01-20
LU91592I2 (fr) 2009-10-12
EP0471726B1 (en) 1997-01-08
EP0471726B2 (en) 2008-05-14
DE122009000041I1 (de) 2009-11-05
EP0747058A1 (en) 1996-12-11
DE69034166D1 (de) 2004-10-28
DE69029656D1 (de) 1997-02-20
NL980007I1 (nl) 1998-04-01
DK0747058T3 (da) 2005-01-10
ES2095874T5 (es) 2008-11-01
DE122005000014I1 (de) 2005-06-23
NL300400I1 (en) 2009-10-01
NL300401I1 (en) 2009-10-01
LU91591I2 (fr) 2009-10-12
DE122005000016I1 (de) 2005-06-23
DE122009000044I1 (de) 2009-11-05
LU91595I2 (fr) 2009-10-12
LU91155I2 (fr) 2005-06-23
DE122005000017I1 (de) 2005-06-23
ATE422900T1 (de) 2009-03-15
DK0471726T3 (da) 1997-03-03
DE122009000042I1 (de) 2009-11-05
ES2230555T3 (es) 2005-05-01
NL300185I1 (nl) 2005-06-01
LU91152I2 (fr) 2005-06-23

Similar Documents

Publication Publication Date Title
NL300184I1 (nl) Acellulair vaccin.
ATE179614T1 (de) Herpes simplex virus vp16 impfstoffe

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 471726

Country of ref document: ES